Luis Gustavo Celis Regalado, Constanza Neri Morales, Felipe Alejandro Ilelaty Urbano, José David Cardona Ortegón, Jorge Luis Cortés Jiménez, María Fernanda Maza Malave, Emma Balcázar Muñoz, José Sanabria Vanegas
{"title":"Therapies that Have Shown Efficacy Against COVID-19: A Narrative Review","authors":"Luis Gustavo Celis Regalado, Constanza Neri Morales, Felipe Alejandro Ilelaty Urbano, José David Cardona Ortegón, Jorge Luis Cortés Jiménez, María Fernanda Maza Malave, Emma Balcázar Muñoz, José Sanabria Vanegas","doi":"10.14482/sun.39.02.305.428","DOIUrl":null,"url":null,"abstract":"Background: The new coronavirus disease has accelerated the development of therapeutic guidelines for patients depending on their degree of severity. To date, many drugs have been studied. However, as time passed, only some of these therapeutic groups have been effective and have produced a reduction in patient mortality and morbidity. Methods: A search and identification of articles published in the following electronic data-bases was carried out: PubMed, Clinical Key, Web of Science, and Scopus; for their analysis and selection in English and Spanish. The literature research emphasizes the search for current guidelines on the treatment of COVID-19, including all degrees of severity, seeking the effectiveness of the medication. Results: For each listed drug, its pharmacodynamics, pharmacokinetics, and general re-commendations for use in adult patients with COVID-19, are described. Conclusions: Du-ring the COVID-19 pandemic, numerous groups of drugs have been studied, however, only a select group have shown to have a role in the treatment of the disease. The literature and guidelines support the use of these treatments.","PeriodicalId":39276,"journal":{"name":"Salud Uninorte","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Salud Uninorte","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14482/sun.39.02.305.428","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The new coronavirus disease has accelerated the development of therapeutic guidelines for patients depending on their degree of severity. To date, many drugs have been studied. However, as time passed, only some of these therapeutic groups have been effective and have produced a reduction in patient mortality and morbidity. Methods: A search and identification of articles published in the following electronic data-bases was carried out: PubMed, Clinical Key, Web of Science, and Scopus; for their analysis and selection in English and Spanish. The literature research emphasizes the search for current guidelines on the treatment of COVID-19, including all degrees of severity, seeking the effectiveness of the medication. Results: For each listed drug, its pharmacodynamics, pharmacokinetics, and general re-commendations for use in adult patients with COVID-19, are described. Conclusions: Du-ring the COVID-19 pandemic, numerous groups of drugs have been studied, however, only a select group have shown to have a role in the treatment of the disease. The literature and guidelines support the use of these treatments.
背景:新型冠状病毒疾病加快了根据患者严重程度制定治疗指南的步伐。迄今为止,已经研究了许多药物。然而,随着时间的推移,这些治疗组中只有一些是有效的,并且降低了患者的死亡率和发病率。方法:对PubMed、Clinical Key、Web of Science、Scopus等电子数据库中发表的文章进行检索和鉴定;用英语和西班牙语进行分析和选择。文献研究强调寻找COVID-19治疗的现行指南,包括所有严重程度,寻求药物的有效性。结果:描述了每种列出的药物的药效学、药代动力学以及对成年COVID-19患者的一般建议。结论:在COVID-19大流行期间,研究了许多组药物,然而,只有一组精选药物显示出在治疗该疾病方面的作用。文献和指南支持使用这些治疗方法。